# Extracorporeal cfDNA Removal in Septic Shock Patients With Elevated DNA Levels

> **NCT07657767** · NA · NOT_YET_RECRUITING · sponsor: **Sergey Savko** · enrollment: 60 (estimated)

## Conditions studied

- Sepsis

## Interventions

- **DEVICE:** Extracorporeal therapy
- **DEVICE:** Extracorporeal elimination of cfDNA using "Nucleocore"

## Key facts

- **NCT ID:** NCT07657767
- **Lead sponsor:** Sergey Savko
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-10
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-02-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07657767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07657767, "Extracorporeal cfDNA Removal in Septic Shock Patients With Elevated DNA Levels". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07657767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*